Cargando…

Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most highly malignant and lethal cancers of the world. Its pathogenesis has been reported to be multi-factorial, and the molecular carcinogenesis of HCC can not be attributed to just a few individual genes. Based on the microRNA and mRNA expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Lin, Lian, Baofeng, Zhang, Yuannv, Li, Wei, Gu, Jianren, He, Xianghuo, Xie, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046763/
https://www.ncbi.nlm.nih.gov/pubmed/24564407
http://dx.doi.org/10.1186/1471-2164-15-S1-S13
_version_ 1782480307158515712
author Wei, Lin
Lian, Baofeng
Zhang, Yuannv
Li, Wei
Gu, Jianren
He, Xianghuo
Xie, Lu
author_facet Wei, Lin
Lian, Baofeng
Zhang, Yuannv
Li, Wei
Gu, Jianren
He, Xianghuo
Xie, Lu
author_sort Wei, Lin
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most highly malignant and lethal cancers of the world. Its pathogenesis has been reported to be multi-factorial, and the molecular carcinogenesis of HCC can not be attributed to just a few individual genes. Based on the microRNA and mRNA expression profiling of normal liver tissues, pericancerous hepatocellular tissues and hepatocellular carcinoma tissues, we attempted to find prognosis related gene sets for HCC patients. RESULTS: We identified differentially expressed genes (DEG) from three comparisons: Cancer/Normal, Cancer/Pericancerous and Pericancerous/Normal. GSEA (gene set enrichment analysis) were performed. Based on the enriched gene sets of GO terms, pathways and transcription factor targets, it was found that the genome instability and cell proliferation increased while the metabolism and differentiation decreased in HCC tissues. The expression profile of DEGs in each enriched gene set was used to correlate to the postoperative survival time of HCC patients. Nine gene sets were found to prognostic correlation. Furthermore, after substituting DEG-targeting-microRNA for DEG members of each gene set, two gene sets with the microRNA expression profiles were obtained that had prognostic potential. CONCLUSIONS: The malignancy of HCC could be represented by gene sets, and pericancerous liver exhibits important characteristics of liver cancer. The expression level of gene sets not only in HCC but also in the pericancerous liver showed potential for prognosis implying an option for HCC prognosis at an early stage. Additionally, the gene-targeting-microRNA expression profiles also showed prognostic potential, demonstrating that the multi-factorial molecular pathogenesis of HCC is contributed by various genes and microRNAs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2164-15-S1-S13) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4046763
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40467632014-06-06 Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma Wei, Lin Lian, Baofeng Zhang, Yuannv Li, Wei Gu, Jianren He, Xianghuo Xie, Lu BMC Genomics Proceedings BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most highly malignant and lethal cancers of the world. Its pathogenesis has been reported to be multi-factorial, and the molecular carcinogenesis of HCC can not be attributed to just a few individual genes. Based on the microRNA and mRNA expression profiling of normal liver tissues, pericancerous hepatocellular tissues and hepatocellular carcinoma tissues, we attempted to find prognosis related gene sets for HCC patients. RESULTS: We identified differentially expressed genes (DEG) from three comparisons: Cancer/Normal, Cancer/Pericancerous and Pericancerous/Normal. GSEA (gene set enrichment analysis) were performed. Based on the enriched gene sets of GO terms, pathways and transcription factor targets, it was found that the genome instability and cell proliferation increased while the metabolism and differentiation decreased in HCC tissues. The expression profile of DEGs in each enriched gene set was used to correlate to the postoperative survival time of HCC patients. Nine gene sets were found to prognostic correlation. Furthermore, after substituting DEG-targeting-microRNA for DEG members of each gene set, two gene sets with the microRNA expression profiles were obtained that had prognostic potential. CONCLUSIONS: The malignancy of HCC could be represented by gene sets, and pericancerous liver exhibits important characteristics of liver cancer. The expression level of gene sets not only in HCC but also in the pericancerous liver showed potential for prognosis implying an option for HCC prognosis at an early stage. Additionally, the gene-targeting-microRNA expression profiles also showed prognostic potential, demonstrating that the multi-factorial molecular pathogenesis of HCC is contributed by various genes and microRNAs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2164-15-S1-S13) contains supplementary material, which is available to authorized users. BioMed Central 2014-01-24 /pmc/articles/PMC4046763/ /pubmed/24564407 http://dx.doi.org/10.1186/1471-2164-15-S1-S13 Text en © Wei et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Proceedings
Wei, Lin
Lian, Baofeng
Zhang, Yuannv
Li, Wei
Gu, Jianren
He, Xianghuo
Xie, Lu
Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma
title Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma
title_full Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma
title_fullStr Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma
title_full_unstemmed Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma
title_short Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma
title_sort application of microrna and mrna expression profiling on prognostic biomarker discovery for hepatocellular carcinoma
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046763/
https://www.ncbi.nlm.nih.gov/pubmed/24564407
http://dx.doi.org/10.1186/1471-2164-15-S1-S13
work_keys_str_mv AT weilin applicationofmicrornaandmrnaexpressionprofilingonprognosticbiomarkerdiscoveryforhepatocellularcarcinoma
AT lianbaofeng applicationofmicrornaandmrnaexpressionprofilingonprognosticbiomarkerdiscoveryforhepatocellularcarcinoma
AT zhangyuannv applicationofmicrornaandmrnaexpressionprofilingonprognosticbiomarkerdiscoveryforhepatocellularcarcinoma
AT liwei applicationofmicrornaandmrnaexpressionprofilingonprognosticbiomarkerdiscoveryforhepatocellularcarcinoma
AT gujianren applicationofmicrornaandmrnaexpressionprofilingonprognosticbiomarkerdiscoveryforhepatocellularcarcinoma
AT hexianghuo applicationofmicrornaandmrnaexpressionprofilingonprognosticbiomarkerdiscoveryforhepatocellularcarcinoma
AT xielu applicationofmicrornaandmrnaexpressionprofilingonprognosticbiomarkerdiscoveryforhepatocellularcarcinoma